期刊文献+

哌拉西林钠他唑巴坦钠致大疱表皮松解型药疹1例 被引量:6

下载PDF
导出
摘要 病例:患者,女,73岁。因“肺部感染、颅内动脉瘤术后”于2012年12月11日夜间入院治疗。立即给予患者注射用阿奇霉素0.5g静脉滴注,每日1次抗感染治疗,患者一般情况无明显改善,考虑患者为老年患者且多次入院,曾行气管切开术,于12日将抗菌药物调整:勾注射用哌拉西林他唑巴坦钠 原液皮试阴性,华北制药.批号:
出处 《中国药物警戒》 2013年第11期703-704,共2页 Chinese Journal of Pharmacovigilance
  • 相关文献

参考文献8

二级参考文献45

  • 1王侠生,孙清娟.重症药疹104例临床分析[J].临床皮肤科杂志,1993,22(4):187-189. 被引量:58
  • 2王侠生,李慎秋,方丽华.大疱性表皮坏死松解型药疹──43例回顾性研究[J].临床皮肤科杂志,1994,23(6):311-313. 被引量:34
  • 3[1]Libermore DM. Determinants of the activity of β-lactamase inhibitor combinations. J Antimicrob Chemother, 1993, 31 (Suppl A):9
  • 4[2]Jones RN, Pfaller MA,Doern GV, et al. Antimicrobial activity and spectrum investigation of eight broad-spectrum β-lactam drugs:a 1997 surveillance trial in 102 medical centers in the United States. Diagn Microbiol Inect Dis,1998,30:215
  • 5[3]Pfaller MA,Jones RN,Doern GV,et al. Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Veneauela using the E test method. Diagn Microbiol Infect Dis,1998,30:45
  • 6[4]Marshall SA,Aldridge KE, Allen SD, et al. Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. Diagn Microbiol Infect Dis, 1995,21:153
  • 7[5]Klepser ME,Marangos MN ,Zhuz, et al. Comparation of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococus faecalis, Escherichia coli, and Pseudomonas aeruginosa. Antimicrob Agents Chemother, 1997,41:435
  • 8[6]Shales DM, Norden C. Piperacillin-tazobactam compared to ticarcillin-clavulanate in community-acquired bacterial lower respiratory tract infection. 33rd ICAAC,New orleans, Louisianna, USA1993,Abstract 646
  • 9[7]Tan JS,Wishnow RM,Talan DA, et al. Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind ,randomized ,multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. Antimicro Agent Chemothe, 1993,37:1580
  • 10[8]Comerra A, Zinner S, Bock R, et al. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother, 1995,39:445

共引文献109

同被引文献46

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部